Ceftibuten
Showing 1 - 9 of 9
Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten, Xeruborbactam Oral Prodrug Placebo)
Not yet recruiting
- Bacterial Infections
- Xeruborbactam Oral Prodrug
- +3 more
- (no location specified)
Oct 6, 2023
Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten)
Not yet recruiting
- Bacterial Infections
- Xeruborbactam Oral Prodrug
- Ceftibuten
- (no location specified)
Nov 27, 2023
Healthy Subjects Trial in Groningen (VNRX-7145, VNRX-5024 (ceftibuten), Placebo)
Completed
- Healthy Subjects
- VNRX-7145
- +2 more
-
Groningen, NetherlandsPRA Health Sciences - Early Development Services
Jun 14, 2022
Healthy Trial in Brussels (Placebo, PF-07612577, PF-06264006)
Recruiting
- Healthy
- Placebo
- +2 more
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Nov 22, 2022
Osteomyelitis Trial in Louisville (oral antibiotics, intravenous antibiotics)
Terminated
- Osteomyelitis
- oral antibiotics
- intravenous antibiotics
-
Louisville, KentuckyUniversity of Louisville
Apr 2, 2021
Urinary Tract Infections Trial in Italy (Amoxicillin and Clavulanic Acid in Oral Dose Form)
Recruiting
- Urinary Tract Infections
- Amoxicillin and Clavulanic Acid in Oral Dose Form
-
Bologna, Emilia Romagna, Italy
- +12 more
Dec 7, 2021
Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)
Completed
- Atrial Fibrillation
- Marevan®
- +2 more
-
São Paulo, BrazilHospital São Paulo/Hospital Universitário da UNIFESP (University
Nov 21, 2016
Pyelonephritis Trial in Triest (ceftibuten)
Terminated
- Pyelonephritis
- ceftibuten
-
Triest, ItalyInstitute for Child Health Burlo Garofolo
Feb 15, 2012